Veeva Systems Inc.
NYSE:VEEVMedical - Healthcare Information Services
-$2.83 today
- Market cap
- $44.88B
- Beta
- 0.95
- P/E (TTM)
- 26.4
- EPS (TTM)
- $5.76
Volume 2.74M
Average 3.01M
VEEV Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Veeva Systems Inc.NYSE: VEEV
Cost of Revenue · Q2 FY2027 · quarter ended Jul 2026
Cost of revenue grows in line with its trailing trend
Q2 FY2027 cost of revenue of $232.01M rose 18.8% year over year, behind the +19.8% change in trailing-twelve-month cost of revenue. Sequentially, it rose 3.9% from the prior quarter. Over 3 fiscal years it compounded at +8.7% a year.
Context
- Cost of revenue amounted to 24.5% of revenue in FY2026, down 1.0 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +18.8% toward the trailing-twelve-month pace of +19.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2026
- 782.02M USD
- Year-over-year change
- +11.8%
- 4-year CAGR
- +11.6%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 782.02M | +11.8% |
| FY2025 | 2025-01-31 | 699.64M | +3.3% |
| FY2024 | 2024-01-31 | 677.29M | +11.1% |
| FY2023 | 2023-01-31 | 609.41M | +21.0% |
| FY2022 | 2022-01-31 | 503.68M | — |
Cost of Revenue vs competitors
How VEEV compares with its peers on the latest reported figures
- VEEV's LTM Jul 2026 cost of revenue of $868.21M is the 2nd highest of the 5 companies compared; the peer median is $110.58M.
- Its year-over-year change of +19.8% is the 3rd highest of 5, against a peer median of +16.1%.
- Cost of revenue amounts to 25.1% of revenue for VEEV, versus a peer median of 38.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $12.53B | +21.4% | +5.1% | 73.8% | |
| LTM Jul 2026 | $868.21M | +19.8% | +8.7% | 25.1% | |
| LTM Sep 2026 | $111.68M | +3.9% | +12.3% | 41.5% | |
| LTM Mar 2026 | $109.48M | +10.8% | +5.6% | 35.1% | |
| LTM Sep 2026 | $87.15M | +43.2% | +9.6% | 13.2% | |
| Peer median (excluding VEEV) | $110.58M | +16.1% | +7.6% | 38.3% | |
Competitors are the stored peer set for VEEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 1.85B | 2.16B | 2.36B | 2.75B | 3.2B |
| Cost of Revenue | 503.68M | 609.41M | 677.29M | 699.64M | 782.02M |
| Gross Profit | 1.35B | 1.55B | 1.69B | 2.05B | 2.41B |
| Gross Margin | 72.8% | 71.7% | 71.3% | 74.5% | 75.5% |
| Research & Development | 382.04M | 520.28M | 629.03M | 693.08M | 767.39M |
| Selling, General & Admin | 459.57M | 566.29M | 628.02M | 662.47M | 729.54M |
| Operating Expenses | 841.6M | 1.09B | 1.26B | 1.36B | 1.5B |
| Depreciation & Amortization | 27.45M | 29.12M | 32.63M | 39.38M | 50.47M |
| EBITDA | 539.76M | 538.22M | 620.65M | 958.76M | 1.24B |
| EBITDA Margin | 29.2% | 25.0% | 26.3% | 34.9% | 39.0% |
| Operating Income | 505.5M | 459.09M | 429.33M | 691.44M | 916.37M |
| Operating Margin | 27.3% | 21.3% | 18.2% | 25.2% | 28.7% |
| Interest Income | 14.73M | 45.86M | 133.75M | 207.99M | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 6.82M | 50.01M | 158.69M | 227.95M | 278.14M |
| Income Before Tax | 512.31M | 509.1M | 588.02M | 919.38M | 1.19B |
| Pre-Tax Margin | 27.7% | 23.6% | 24.9% | 33.5% | 37.4% |
| Income Tax Expense | 84.92M | 21.39M | 62.32M | 205.24M | 285.6M |
| Net Income | 427.39M | 487.71M | 525.71M | 714.14M | 908.91M |
| Net Margin | 23.1% | 22.6% | 22.2% | 26.0% | 28.4% |
| EPS (Basic) | 2.79 | 3.14 | 3.27 | 4.41 | 5.55 |
| EPS (Diluted) | 2.63 | 3.00 | 3.22 | 4.32 | 5.44 |
| Weighted Avg Shares | 153.25M | 155.39M | 160.53M | 161.88M | 163.67M |
| Weighted Avg Shares (Diluted) | 162.28M | 162.44M | 163.49M | 165.23M | 167M |
Veeva Systems Inc.
NYSE:VEEV
Intrinsic Alpha fair value
Locked
Current Price
$277.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.